Tel.: +33 (0)9 72 56 94 99

News

Choose a news type

All
Congresses
General
Non classé
Publications

Inoviem Scientific participates in the Galien MedStartUp event taking place in New York, October 25-26 2017
Aug 2017

Strasbourg – August 2017 Inoviem Scientific is happy to announce that it has been selected along with 50 French innovative companies to participate in the Galien MedStartUp event taking place in New York on the 25th and 26th of October 2017. Dr Pierre Eftekhari and Dr Daniel Da Costa would be pleased to meet any […]

LEARN MORE

Inoviem Scientific appoints Michel Hubert as a new member of its supervisory board
Aug 2017

Strasbourg – August 2017 Inoviem Scientific is happy to announce that Michel HUBERT, president and founder of NHBP Consulting has joined its supervisory board. With 25 years of experience in business development by Abbott Laboratories, Solvay Pharmaceuticals, Novartis, Transgene, Laboratoires Fournier and Rhône-Poulenc (now Sanofi), Inoviem hopes to benefit from his outstanding track record of […]

LEARN MORE

Inoviem Scientific approved by the French Ministry of Research for the Research Tax Credit «Crédit d’Impôt Recherche»
Jul 2017

Strasbourg – July 2017 Inoviem Scientific has received for the second time the approval for the research tax credit « Credit d’Impôt Recherche – CIR » from the French Ministry of Research. Any pharma or biotech companies located in France can benefit from this research tax credit if it contracts any service with Inoviem Scientific […]

LEARN MORE

MEET INOVIEM AT THE 18th ANNUAL DRUG DISCOVERY SUMMIT IN BERLIN, JUNE 12-13, 2017
Jun 2017

Inoviem Scientific will be present at the 18th Annual Drug Discovery Summit taking place on the 12-13 June 2017, in Berlin Germany. This summit takes place at the Hotel Palace and gathers key actors of the field around new trends and latest innovations in drug discovery. Catch the opportunity to meet our founder Dr Pierre […]

LEARN MORE

Inoviem Scientific raises €750k ($800k) from existing financial partners
Apr 2017

Strasbourg, April 18.  Inoviem Scientific announces to have raised €750’000 ($800’000) from its existing financial partners (Cap Innov’Est, BPI France, Eurometropole and its banks). Inoviem Scientific will allocate the resources for the development of complementary solutions in order to expand its label-free technical analysis, and for the expansion of its commercial activity. Inoviem Scientific has already […]

LEARN MORE

Meet Inoviem Scientific at BioEurope Spring in Barcelona, March 20-22, 2017
Mar 2017

Inoviem Scientific participates to BIO-Europe Spring 2017 in Barcelona, March 20-22. Meet our Business development manager, Daniel Da Costa to talk about our unique proprietary label-free technologies for drug-target interaction analysis. BioEurope conference will be also the opportunity to know more about the recent developments at Inoviem Scientific, and the new opportunities for your drug […]

LEARN MORE

Inoviem Scientific moves to new facilities
Jan 2017

Strasbourg; January 12, 2016 – Inoviem Scientific announces the company has moved from 156 m2 premises at ISIS (Institut de Science et d’Ingénierie Supramoléculaires) to its brand new 560 m2 facilities. R&D and sales will from now on take place and be managed in Bioparc 3 situated at the innovation park in Illkirch-Graffenstaden, France. The […]

LEARN MORE

Inoviem Announces ISO 9001:2015 Certification
Jan 2017

Strasbourg, December 28, 2016 – Inoviem Scientitic is proud to announce that another milestone has crossed its development. Continuing in their commitment to excellence and respect for life, Inoviem was granted with the latest edition of ISO 9001 Quality Management certificate by AFNOR (Association Française de NORmalisation). This certification is an important step in assuring […]

LEARN MORE

Meet Inoviem Scientific at the Bio-Europe conference in Cologne on November 7-9, 2016.
Oct 2016

Inoviem Scientific will attend the 22nd Annual International partnering conference BIO-EUROPE in Cologne. This conference is the leading partnering event in Europe where it welcomes every year more than 1800 companies from all around the world. Partnering deals occurring at Bio-Europe conference tend to shape the European pharma industry. This conference is thus the perfect […]

LEARN MORE

Meet Inoviem Scientific at the Euro-Global Summit on Toxicology and Applied Pharmacology, on October 24-26, 2016.
Oct 2016

The 7th Euro-Global Summit on Toxicology and Applied Pharmacology will take place in Rome, Italy, from the 24th to the 26th of October 2016. This summit gathers and welcomes every year in Europe the most renowned Toxicologist in the world to talk about the latest breakthroughs in the field. Dr Pierre Eftekhari has been invited […]

LEARN MORE

Inoviem Scientific appoints Dr Rachel Amouroux, Head of Research
Sep 2016

Strasbourg, September 1, 2016. Inoviem Scientific strengthen its R&D department and appoints Dr Rachel Amouroux, Head of  Research. Dr Amouroux holds a PhD in Molecular Biology from the University Pierre et Marie Curie in Paris, with a major in genetics. Prior to joining Inoviem Scientific, Dr Amouroux was research associate at the Institute of Clinical […]

LEARN MORE

Meet Inoviem Scientific at the annual IDDST congress in Gyeonggi, South Korea on June 16-18 2016
Jun 2016

The BIT’S 14th Annual Congress of IDDST is the perfect moment to meet Inoviem Scientific. This congress is focused on how breaking research should overcome the barriers in new therapeutic innovation. Inoviem Scientific has been invited to take part in the discussions and present its cutting-edge approach of studying toxicology already at early preclinical development. […]

LEARN MORE

BPI France rewards the corporate project of Inoviem Scientific by entering BPI France Excellence club.
Feb 2016

Inoviem Scientific is now part of the BPI France Excellence club which gather more than 3000 French strategic companies rewarded for their long-term corporate projects. BPI France is the French Public Investment bank and it supports companies with high growth potential in the development of their business. BPI France will finance 8 billion euros in […]

LEARN MORE

Meet Inoviem Scientific at the BioEurope Spring in Stockholm on April 4-6 2016
Feb 2016

The 10th Annual International Partnering Conference BioEurope is the perfect moment to meet Inoviem Scientific and to know more about its unique label-free cutting-edge technologies and the recent developments of the company. Inoviem Scientific supports pharma and biotech companies or academic groups involved in the challenge of drug development. We offer the possibility to benefit […]

LEARN MORE

Inoviem Scientific obtains €545’000 in loans from BPI France, the french public investment bank.
May 2015

Strasbourg, May 12 2015, Inoviem Scientific announces to .have received €545’000 ($611’000) in loans from the french public investment bank BPI France. This investment will allow Inoviem to automatise its technologies and should lead to first prototypes by the end of the year. Technologies automatisation will lead to a consequent increase in sample analysis capacity […]

LEARN MORE

Inoviem Scientific Raises €500’000 ($566’000) in seed funding from Cap Innov’ Est
Feb 2015

Strasbourg, February 10. Inoviem Scientific announces to have raised €500’000 ($566’000) from Cap Innov’ Est in seed funding. Inoviem Scientific aims to put its ‘label-free’ drug discovery optimization technologies into production and ramp up its European expansion. More information on the press release available in french or english!

LEARN MORE

Inoviem Scientific rewards Prof. Heike Allgayer
Jan 2015

Strasbourg – January 5. The Inoviem Scientific Excellence Award has been created to support scientific excellence among academic researchers. It supports a researcher that dedicates its research to answer an unmet medical need through an innovative approach. After 9 weeks of contest, the scientific board has the great pleasure to announce that Professor Heike Allgayer […]

LEARN MORE

Meet Inoviem Scientific in Boston at the 2nd International Conference on Label-Free Technologies
Jan 2015

March 12-14, 2015, Inoviem Scientific will participate at the 2nd International Conference on Label-Free Technologies, which will take place in Boston, USA. Label-free technologies is a two-and-a-half day conference focused on the latest advances and applications of a label-free technology in life sciences and drug discovery. Inoviem Scientific will present the two proprietary label-free cutting-edge technologies […]

LEARN MORE

Inoviem Scientific approved by the French Ministry of Research for the Research Tax Credit «Crédit d’impôt recherche»
Nov 2014

Strasbourg – November 2014. Inoviem Scientific, as an innovative start-up company with cutting-edge technologies, has received the approval for the research Tax credit « Credit d’Impôt Recherche – CIR » from the French Ministry of Research. The CIR approval is delivered to companies performing research projects as the sign of recognition for their technical skills […]

LEARN MORE

Inoviem Scientific launches an Award to support Scientific Excellence
Oct 2014

Strasbourg. October 27, 2014. Inoviem Scientific defends core values among which scientific excellence represents a pillar that shapes our thinking, guide our research, management style and business practices. In order to promote and share this value, Inoviem Scientific launches an award to support scientific excellence. The Inoviem Scientific Excellence Award aims to encourage scientific excellence amongst researchers […]

LEARN MORE

Inoviem Scientific expands its operational capacity within the ISIS institute
Oct 2014

Strasbourg, October 1, 2014 In order to meet the growing demand, Inoviem Scientific has expanded its operational capacity within the Institut de Sciences et d’Ingénierie Supramoléculaire (ISIS), 8 allée Gaspard Monge, Strasbourg, France. Inoviem Scientific benefits now of a total of 110m² of laboratory and 25m² of offices within the ISIS institute. These new premises […]

LEARN MORE

Meet Inoviem Scientific in Chicago at the 3rd International Summit on Toxicology and Applied Pharmacology
Jun 2014

October 20-22, 2014, Inoviem Scientific will participate in the 3rd International Summit on Toxicology and Applied Pharmacology, which will take place in Chicago, USA. Inoviem Scientific has been invited to present the NPOT® technology and its potential for drug development and drug upgrade programs. Dr Pierre Eftekhari, Founder and President of Inoviem Scientific will present “NPOT®, […]

LEARN MORE

Dr Serge Braun has been elected at the National Academy of Pharmacy
Apr 2014

Inoviem Scientific is proud to announce the election of Dr Serge Braun, a member of Inoviem’ Scientific Board, as member of the National Academy of Pharmacy. Dr Serge Braun obtained a doctor degree in Pharmacy and a PhD in Pharmacology from Louis Pasteur University, Strasbourg. He dedicated his research to neuromuscular diseases and worked for Transgene, […]

LEARN MORE

Inoviem Scientific reinforce its research team
Feb 2014

Inoviem Scientific has recently reinforced its research team by recruiting Dr Judith Eschbach. Dr Judith Eschbach holds a PhD in molecular biology with a major in Neurosciences from the University of Strasbourg. Prior to working at Inoviem Scientific, Dr Eschbach was research associate at the Ulm University (Germany). Inoviem Scientific employ now 7 collaborators and […]

LEARN MORE

Meet Inoviem Scientifc at the 9th Congress of the European Crohn’s and colitis organization in Coppenhagen.
Feb 2014

In collaboration with Erlangen and Ingolstadt hospitals, Inoviem Scientific has realized a longitudinal study for the prediction of response to anti-TNF therapy with 37 patients suffering from IBD, using its cutting-edge technology, PIMS®. Results of this longitudinal study will be presented on the 20th of February at the 9th congress of the European Chron’s and Colitis Organisation […]

LEARN MORE

Physiological intermolecular modification spectroscopy (PIMS®®) for the prediction of response to anti-TNF therapy in patients with inflammatory bowel diseases.
Feb 2014

Background/Aims Anti-TNF antibodies have clincial efficiency only in a subgroup of patients with inflammatory bowel diseases (IBD). Prediction of clinical responsiveness is a critical clinical problem. Physiological intermolecular modification spectroscopy (PIMS®) is a label free technology, performed in physiological conditions. PIMS® is a real time, dynamic molecular resonance of entire proteins and macromolecules of an individual. The aim of this […]

LEARN MORE

Inoviem Scientific receives French President, Mr François Hollande.
Jan 2014

President François Hollande visited Inoviem Scientific during his official visit to Strasbourg January 30, 2014. The President also met another highly innovative Start-up as well as the Nobel Prizes laureates in Chemistry (1987 & 2013), Pr Jean-Marie Lehn and Pr Martin Karplus during his visit at the Institut de Sciences et d’Ingénierie Supramoléculaire (ISIS).

LEARN MORE

Inoviem Scientific appoints Daniel Da Costa as Communications and Commercial Officer
Oct 2013

Inoviem Scientific appoints Dr Daniel Da Costa, communications and commercial officer, CCO. Dr Daniel Da Costa graduated from Ecole Normale Supérieure de Lyon (ENS Lyon) and hold a PhD in molecular biology with a major in virology from the University of Strasbourg. Dr Da Costa also has a master in innovation management from the University […]

LEARN MORE

Inoviem Scientific expand its operational capacity by adding new laboratory and office space
Oct 2013

In order to meet the growing demand, Inoviem Scientific has expanded its operational capacity by moving into new modern facilities at the Institut de Science et d’Ingénierie Supramoléculaire (ISIS), 8 allée Gaspard Monge, Strasbourg, France. Inoviem Scientific also keeps its office and laboratory at the IPCB, l’Institut de Physiologie, Chimie et Biologie, 21 rue René Descartes, Strasbourg, and […]

LEARN MORE

Inoviem Scientific appoints its Scientific board.
Jul 2013

Inoviem Scientific has the pleasure to announce that the following prominent scientists have accepted to join the company’s international scientific board: Pr Sylviane Muller Dr Alain Wagner Dr Serge Braun Dr Johan Hoebeke Dr Jörg Wischhusen Uncover their expertise here.

LEARN MORE

Inoviem Scientific appoints Frédéric Perraud as Chief Financial officer
Jun 2013

Inoviem Scientific appointed Dr Frederic Perraud, Chief Financial Officer, CFO. Dr Perraud has a strong experience in biotech company management. He is a life-science entrepreneur with over 10 years of executive positions such as CFO, COO or CEO, in the following biotech companies:  Transgene, a Biomerieux’ company, Neurofit, a CRO dedicated to behavioural studies for […]

LEARN MORE

Inoviem Scientific presents the results of a transversal clinical study using PIMS® technology at the Falk Symposium. London.
Jun 2013

In collaboration with Erlangen and Ingolstadt hospitals, Inoviem Scientific has realized a transversal study for the prediction of response to anti-TNF therapy with 47 patients suffering from IBD, using its cutting-edge technology, PIMS®. Results of this transversal study have been presented to the Falk International Symposium and Inoviem Scientific have been awared the best oral […]

LEARN MORE

Inoviem Scientific is created.
Nov 2011

Inoviem Scientific has been founded by Dr Pierre Eftekhari, who developed the cutting-edge technologies, which are the basis of the company. Inoviem Scientific will deliver high-added value services to pharmaceutical and biotech companies.

LEARN MORE